Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Sep 1, 2026
Patterns of Multimorbidity among Older Adults with Colorectal Cancer Living in Puerto Rico.
Read at PubMed CentralPubMed Central · Aug 31, 2026
P53 Competitively Binds P300 to Suppress HIF-1α/TFRC-Mediated Ferroptosis and Promote Doxorubicin Resistance in Breast Cancer.
Read at PubMed CentralPubMed Central · Aug 31, 2026
Clinicopathological features, morbidity and survival in gastric adenocarcinoma, with a focus on stage III: a retrospective institutional cohort analysis.
Read at PubMed CentralPubMed Central · Aug 31, 2026
Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential.
Read at PubMed CentralPubMed Central · Aug 31, 2026
PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis.
Read at PubMed CentralPubMed Central · Aug 31, 2026
Clinicopathologic features and prognostic factors in early- versus late-onset colorectal cancer: a stage-stratified retrospective surgical cohort from the Mekong Delta, Vietnam.
Read at PubMed CentralPubMed Central · Aug 31, 2026
CT radiomics-histopathological correlation for mediastinal lymph node staging in non-small cell lung cancer.
Read at PubMed CentralPubMed Central · Aug 31, 2026
Curcumin-Loaded Cellulose Nanofibers for Breast Cancer Therapy: A Multiscale Computational and Experimental Evaluation.
Read at PubMed CentralPubMed Central · Aug 31, 2026
Computational identification and evaluation of Adenium obesum phytochemicals as potential EGFR inhibitors for targeted therapy against non-small-cell lung cancer.
Read at PubMed CentralPubMed Central · Aug 31, 2026
Single-cell RNA sequencing uncovers an immunosuppressive program in PDAC mast cells: tumour-driven activation, proliferation, and association with Treg recruitment.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Engineered Nanozymes for Colorectal Cancer Therapy: Catalytic Reprogramming of the Tumor Microenvironment.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Reprogramming pulmonary B cells by ANXA1 silencing halts lung metastatic niche formation in breast cancer.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors.
Read at PubMed CentralPubMed Central · Aug 29, 2026
FAK regulates leptin-induced angiogenesis and vasculogenic mimicry in breast cancer.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Bladder cancer precision-cut tumor slices (PCTS) preserve functional immune microenvironment enabling ex vivo drug evaluation.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [(225)Ac]Ac-/[(177)Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Impact of robotic platform transition on short term outcomes in colorectal cancer surgeries.
Read at PubMed CentralPubMed Central · Aug 29, 2026
Programmed Death-Ligand 1 (PD-L1) expression and clinical outcomes in oral squamous cell carcinoma: evidence from a large clinical cohort.
Read at PubMed CentralPubMed Central · Aug 28, 2026
Effects on mouse melanoma and immune cells of P2X7 receptor positive allosterism by clemastine.
Read at PubMed Central